Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Retatrutide (development code LY3437943 ) is a single synthetic peptide developed by Eli Lilly that acts as a triple agonist at three receptors simultaneously: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor
Autoimmune Conditions: Certain autoimmune diseases may cause cell damage and disrupt normal vitamin B12 metabolism
COA documentation includes all analytical testing results
A systematic review in 2025 identified one qualifying clinical study: a retrospective analysis in which 7 of 12 subjects with chronic knee pain reported relief for over six months following intra-articular injection
Aplique de 4 a 6 gotas sobre o couro cabeludo limpo e seco, de manh e noite
US$ 28.40
US$ 24.49
US$ 20.33
US$ 21.26
US$ 29.52
US$ 20.90
US$ 26.69
US$ 22.19
US$ 22.55
US$ 25.42
US$ 23.25
US$ 23.89
